Abstract
A collection of both commercial and non-commercial galloyl derivatives (either isolated from plants or synthesized) was examined for an in vitro structure-activity relationship (SAR) screening of their anti-yeast activity. Most of the compounds exhibited an antimycotic activity when used together with amphotericin B (AMB) and none when used alone. The SAR study indicated the presence of two galloyl moieties in adjacent position as an important structural characteristic. In fact, among the compounds tested, 2,3-O-digalloyl-O-methylglucose and 2,3-O-digalloyl-Omethylmannose exhibited a synergistic interaction with AMB against a set of Candida albicans, Candida glabrata and Pichia kudriavzevii strains. A similar biological activity has also been observed for epigallocatechin gallate (EGCG). The high structural similarity between the two digalloyl derivatives and EGCG was advocated as possible rationale to explain their synergy with AMB.
Keywords: Anti-yeast activity, FIC, gallic acid, glucogalloy derivatives, MIC, SAR, synergy.
The Natural Products Journal
Title:In Vitro Synergistic Anti-yeast Activity between Galloyl Derivatives and Amphotericin B
Volume: 3 Issue: 2
Author(s): Panagiotis Arapitsas, Benedetta Turchetti, Fabrizio Melani, Daniela Tacconi, Cristina Nativi, Annalisa Romani, Stefano Menichetti and Pietro Buzzini
Affiliation:
Keywords: Anti-yeast activity, FIC, gallic acid, glucogalloy derivatives, MIC, SAR, synergy.
Abstract: A collection of both commercial and non-commercial galloyl derivatives (either isolated from plants or synthesized) was examined for an in vitro structure-activity relationship (SAR) screening of their anti-yeast activity. Most of the compounds exhibited an antimycotic activity when used together with amphotericin B (AMB) and none when used alone. The SAR study indicated the presence of two galloyl moieties in adjacent position as an important structural characteristic. In fact, among the compounds tested, 2,3-O-digalloyl-O-methylglucose and 2,3-O-digalloyl-Omethylmannose exhibited a synergistic interaction with AMB against a set of Candida albicans, Candida glabrata and Pichia kudriavzevii strains. A similar biological activity has also been observed for epigallocatechin gallate (EGCG). The high structural similarity between the two digalloyl derivatives and EGCG was advocated as possible rationale to explain their synergy with AMB.
Export Options
About this article
Cite this article as:
Arapitsas Panagiotis, Turchetti Benedetta, Melani Fabrizio, Tacconi Daniela, Nativi Cristina, Romani Annalisa, Menichetti Stefano and Buzzini Pietro, In Vitro Synergistic Anti-yeast Activity between Galloyl Derivatives and Amphotericin B, The Natural Products Journal 2013; 3 (2) . https://dx.doi.org/10.2174/2210315511303020008
DOI https://dx.doi.org/10.2174/2210315511303020008 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Role of Lifestyle Change in the Prevention and Treatment of NAFLD
Current Pharmaceutical Design A Review of Eugenol-based Nanomedicine: Recent Advancements
Current Bioactive Compounds Exploring Old Drugs for the Treatment of Hematological Malignancies
Current Medicinal Chemistry Drug Targets for Obesity and Depression: From Serotonin to Leptin
Current Drug Targets Pharmacogenetic Applications of the Post Genomic Era
Current Pharmaceutical Biotechnology Is there any Role for Splenectomy in Adulthood Onset Chronic Immun e Thrombocytopenia in the Era of TPO Receptors Agonists? A Critic al Overview
Cardiovascular & Hematological Disorders-Drug Targets Factor VIII Levels are Associated with Ischemic Stroke, Stroke Subtypes and Neurological Worsening
Current Neurovascular Research Strategies for the Assessment of Metabolic Profiles of Steroid Hormones in View of Diagnostics and Drug Monitoring: Analytical Problems and Challenges
Current Drug Metabolism Collagenolytic Enzymes and their Applications in Biomedicine
Current Medicinal Chemistry New Genetic and Pharmacological Treatments for Cystic Fibrosis
Current Pediatric Reviews Damnacanthal-Induced Anti-Inflammation is Associated with Inhibition of NF-κB Activity
Inflammation & Allergy - Drug Targets (Discontinued) Preclinical and Clinical Studies of Chidamide (CS055/HBI-8000), An Orally Available Subtype-selective HDAC Inhibitor for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Evaluation of Antioxidant Activity of Phytol Using Non- and Pre-Clinical Models
Current Pharmaceutical Biotechnology Neopterin: From Forgotten Biomarker to Leading Actor in Cardiovascular Pathophysiology
Current Vascular Pharmacology Towards Improved Therapies Using Nanopharmaceuticals: Recent Patents on Pharmaceutical Nanoformulations
Recent Patents on Food, Nutrition & Agriculture Porphyromonas gingivalis Gingipains: The Molecular Teeth of a Microbial Vampire
Current Protein & Peptide Science Is There an Association between Periodontitis and Hypertension?
Current Cardiology Reviews Role of Ascorbic Acid in Cardiovascular Performance During Acute Hemorrhage
Vascular Disease Prevention (Discontinued) The Antioxidant Activity of Coumarins and Flavonoids
Mini-Reviews in Medicinal Chemistry Resveratrol and Cancer: Chemoprevention, Apoptosis, and Chemoimmunosensitizing Activities
Current Medicinal Chemistry - Anti-Cancer Agents